Risk factors for local recurrence of middle and lower rectal carcinoma after curative resection

World Journal of Gastroenterology

Volumn 14, Issue 30, 2008, Pages 4805-4809

  Yu, Ze Yu ^a   Wan, Jin ^a   Zhao, Gang ^a   Peng, Lin ^a   Du, Jia Lin ^a   Yao, Yuan ^a   Liu, Quan Fang ^a   Lin, Hua Huan ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Circumferential resection margin; Local recurrence; Mesorectal metastasis; Middle and lower rectal carcinoma

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER MORPHOLOGY; CANCER RECURRENCE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; RECTUM CARCINOMA; RECTUM RESECTION; RECURRENCE RISK; TUMOR EMBOLISM; ABDOMINAL SURGERY; CANCER INVASION; CARCINOMA; CELL DIFFERENTIATION; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PEDIGREE; RECTUM TUMOR; RISK FACTOR; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; CARCINOMA; CELL DIFFERENTIATION; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PEDIGREE; RECTAL NEOPLASMS; RISK FACTORS; TREATMENT OUTCOME;

EID: 55449134405     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.4805     Document Type: Article

References (27)

1. Noda K, Umekita N, Tanaka S, Ohkubo T, Inoue S, Kitamura M. [A clinical study of therapy for local recurrent rectal cancer] Gan To Kagaku Ryoho 2006; 33: 1830-1833
2. Bedrosian I, Giacco G, Pederson L, Rodriguez-Bigas MA, Feig B, Hunt KK, Ellis L, Curley SA, Vauthey JN, Delclos M, Crane CH, Janjan N, Skibber JM. Outcome after curative resection for locally recurrent rectal cancer. Dis Colon Rectum 2006; 49: 175-182
3. Moriya Y, Akasu T, Fujita S, Yamamoto S. Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer. Surg Oncol Clin N Am 2005; 14: 225-238
4. Radice E, Dozois RR. Locally recurrent rectal cancer. Dig Surg 2001; 18: 355-362
5. Piso P, Dahlke MH, Mirena P, Schmidt U, Aselmann H, Schlitt HJ, Raab R, Klempnauer J. Total mesorectal excision for middle and lower rectal cancer: a single institution experience with 337 consecutive patients. J Surg Oncol 2004; 86: 115-121
6. Rengan R, Paty PB, Wong WD, Guillem JG, Weiser M, Temple L, Saltz L, Minsky BD. Ten-year results of preoperative radiation followed by sphincter preservation for rectal cancer: increased local failure rate in nonresponders. Clin Colorectal Cancer 2006; 5: 413-421
7. Hohenberger W, Merkel S, Matzel K, Bittorf B, Papadopoulos T, Gohl J. The influence of abdomino-peranal (intersphincteric) resection of lower third rectal carcinoma on the rates of sphincter preservation and locoregional recurrence. Colorectal Dis 2006; 8: 23-33
8. Lezoche E, Guerrieri M, De Sanctis A, Campagnacci R, Baldarelli M, Lezoche G, Paganini AM. Long-term results of laparoscopic versus open colorectal resections for cancer in 235 patients with a minimum follow-up of 5 years. Surg Endosc 2006; 20: 546-553
9. Hermanek P, Junginger T. The circumferential resection margin in rectal carcinoma surgery. Tech Coloproctol 2005; 9: 193-199; discussion 199-200
10. Wibe A, Rendedal PR, Svensson E, Norstein J, Eide TJ, Myrvold HE, Soreide O. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 2002; 89: 327-334
11. Hall NR, Finan PJ, al-Jaberi T, Tsang CS, Brown SR, Dixon MF, Quirke P. Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence? Dis Colon Rectum 1998; 41: 979-983
12. Okaro AC, Worthington T, Stebbing JF, Broughton M, Caffarey S, Marks CG. Curative resection for low rectal adenocarcinoma: abdomino-perineal vs anterior resection. Colorectal Dis 2006; 8: 645-649
13. Chiappa A, Biffi R, Bertani E, Zbar AP, Pace U, Crotti C, Biella F, Viale G, Orecchia R, Pruneri G, Poldi D, Andreoni B. Surgical outcomes after total mesorectal excision for rectal cancer. J Surg Oncol 2006; 94: 182-193; discussion 181
14. Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet 2000; 356: 93-96
15. Temple WJ, Saettler EB. Locally recurrent rectal cancer: role of composite resection of extensive pelvic tumors with strategies for minimizing risk of recurrence. J Surg Oncol 2000; 73: 47-58
16. Laurent C, Nobili S, Rullier A, Vendrely V, Saric J, Rullier E. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision. J Am Coll Surg 2006; 203: 684-691
17. Visser O, Bakx R, Zoetmulder FA, Levering CC, Meijer S, Slors JF, van Lanschot JJ. The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: a population-based study in Greater Amsterdam. J Surg Oncol 2007; 95: 447-454
18. Bernardshaw SV, Ovrebo K, Eide GE, Skarstein A, Rokke O. Treatment of rectal cancer: reduction of local recurrence after the introduction of TME-experience from one University Hospital. Dig Surg 2006; 23: 51-59
19. Luna-Perez P, Bustos-Cholico E, Alvarado I, Maffuz A, Rodriguez-Ramirez S, Gutierrez de la Barrera M, Labastida S. Prognostic significance of circumferential margin involvement in rectal adenocarcinoma treated with preoperative chemoradiotherapy and low anterior resection. J Surg Oncol 2005; 90: 20-25
20. Nagtegaal ID, Marijnen CA, Kranenbarg EK, van de Velde CJ, van Krieken JH. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol 2002; 26: 350-357
21. Laurent C, Nobili S, Rullier A, Vendrely V, Saric J, Rullier E. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision. J Am Coll Surg 2006; 203: 684-691
22. Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 1998; 133: 894-899
23. Wan J, Wu ZY, Du JL, Yao Y, Wang ZD, Lin HH, Luo XL, Zhang W. [Mesorectal metastasis of middle and lower rectal cancer] Zhonghua Waike Zazhi 2006; 44: 894-896
24. Sugihara K, Kobayashi H, Kato T, Mori T, Mochizuki H, Kameoka S, Shirouzu K, Muto T. Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum 2006; 49: 1663-1672
25. Das P, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Hoff PM, Eng C, Wolff RA, Janjan NA, Delclos ME, Krishnan S, Levy LB, Ellis LM, Crane CH. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol 2006; 29: 219-224
26. Park YA, Lee KY, Kim NK, Baik SH, Sohn SK, Cho CW. Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer. Ann Surg Oncol 2006; 13: 645-650
27. Oh YT, Kim MJ, Lim JS, Kim JH, Lee KY, Kim NK, Kim WH, Kim KW. Assessment of the prognostic factors for a local recurrence of rectal cancer: the utility of preoperative MR imaging. Korean J Radiol 2005; 6: 8-16